Estimaciones de analistas de Wall Street para NRx Pharmaceuticals, Inc. (NRXP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.26 | ||
| 2026-08-17 | $-0.44 | $-0.11 | -312.5% |
| 2026-05-15 | $-0.04 | $-0.05 | +20.0% |
| 2026-03-23 | $0.19 | $-0.09 | +311.1% |
| 2025-11-17 | $-0.27 | $-0.11 | -145.5% |
| 2025-08-18 | $-0.98 | $-0.15 | -552.7% |
| 2025-05-15 | $-0.34 | $-0.30 | -13.3% |
| 2025-03-17 | $-0.72 | $-0.20 | -262.1% |
Ratios de valoración
| Precio / Valor contable | -741.91 |
| EV / EBITDA | -1.59 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.2M |
| Coste de Ventas | 0 | $1.0M | 0 | $2000 | $2000 | $4000 | $5000 | $5000 | $505000 |
| Beneficio Bruto | 0 | -$1.0M | 0 | -$2000 | -$2000 | -$4000 | -$5000 | -$5000 | $720000 |
| I+D | 0 | 0 | 0 | $10.6M | $20.3M | $17.0M | $13.4M | $6.2M | $3.8M |
| Generales y Administrativos | 0 | $1.0M | $713187 | $11.4M | $74.9M | $27.3M | $14.2M | $13.5M | $13.1M |
| Gastos Operativos | 0 | 0 | $713187 | $22.1M | $95.2M | $44.3M | $27.6M | $19.7M | $16.9M |
| Beneficio Operativo | 0 | -$1.0M | -$713187 | -$22.1M | -$95.2M | -$44.3M | -$27.6M | -$19.7M | -$16.2M |
| EBITDA | -$105000 | $82412 | $492633 | -$51.7M | -$93.0M | -$39.8M | -$30.0M | -$24.0M | -$27.8M |
| Gastos por Intereses | 0 | 0 | 0 | $56000 | $18000 | 0 | $120000 | $1.1M | $671000 |
| Beneficio Antes de Impuestos | -$105000 | $82412 | $492633 | -$51.8M | -$93.1M | -$39.8M | -$30.1M | -$25.1M | -$28.6M |
| Impuestos | 0 | $16311 | $84206 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$105000 | $66101 | $408427 | -$51.8M | -$93.1M | -$39.8M | -$30.1M | -$25.1M | -$28.6M |
| BPA | $-0.12 | $0.07 | $0.80 | $-1.51 | $-7.44 | $-0.60 | $-3.98 | $-2.39 | $-1.34 |
| BPA Diluido | $-0.12 | $0.07 | $0.80 | $-1.51 | $-7.44 | $-0.60 | $-3.98 | $-2.39 | $-1.34 |
| Acciones en Circulación (Diluidas) | $903550 | $892496 | $508835 | $546586 | $46.9M | $65.8M | $7.6M | $10.5M | $21.4M |
Precio
| Precio | $3.35 |
| Capitalización | $58M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: COEP · CUE · EQ · HOWL · IOBT · IPSC · KPTI
Explorar sector: Healthcare · Biotechnology
Más secciones de NRXP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones